A case report of a TDM-guided optimization of mitotane for a safe and effective long-term treatment.
In conclusion, the adoption of therapeutic mitotane monitoring allowed the treatment of an AC patient with a reduced, tolerable and effective dose.
PMID: 30831058 [PubMed - as supplied by publisher]
Source: Journal of Chemotherapy - Category: Cancer & Oncology Tags: J Chemother Source Type: research
More News: Adrenocortical Carcinoma | Cancer & Oncology | Carcinoma | Chemotherapy | Gastroenterology | Toxicology | Weight Loss